LON:APH Alliance Pharma (APH) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesInsider TradesBuy This Stock About Alliance Pharma Stock (LON:APH) 30 days 90 days 365 days Advanced Chart Get Alliance Pharma alerts:Sign Up Key Stats Today's Range N/A50-Day Range 64.70▼ 64.7052-Week Range N/AVolumeN/AAverage Volume5.95 million shsMarket Capitalization£350.32 millionP/E RatioN/ADividend Yield3.75%Price TargetGBX 6,250Consensus RatingHold Company Overview Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom. Read More Alliance Pharma Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks41st Percentile Overall ScoreAPH MarketRank™: Alliance Pharma scored higher than 41% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingAlliance Pharma has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAlliance Pharma has received no research coverage in the past 90 days.Read more about Alliance Pharma's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Alliance Pharma is -10.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alliance Pharma is -10.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioAlliance Pharma has a PEG Ratio of 1.04. PEG Ratios around 1 indicate that a company is correctly valued. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for APH. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipAlliance Pharma is a leading dividend payer. It pays a dividend yield of 3.75%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthAlliance Pharma does not have a long track record of dividend growth.Read more about Alliance Pharma's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for APH. News and Social Media0.6 / 5News SentimentN/A Search Interest34 people have searched for APH on MarketBeat in the last 30 days. This is an increase of 48% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Alliance Pharma insiders have not sold or bought any company stock.Percentage Held by Insiders11.95% of the stock of Alliance Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions66.34% of the stock of Alliance Pharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Alliance Pharma's insider trading history. Receive APH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address APH Stock News HeadlinesRBC Capital Reaffirms Their Hold Rating on Alliance Pharma (APH)March 11, 2025 | markets.businessinsider.comAlliance Pharma Valued at $468 Million Under Increased Offer From Aegros BidcoMarch 10, 2025 | marketwatch.comElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social Security? What we just discovered in Washington will stun even the most seasoned insiders.August 2 at 2:00 AM | Banyan Hill Publishing (Ad)Alliance Pharma agrees £362m takeover by biggest shareholderMarch 10, 2025 | msn.comUK's Alliance Pharma agrees to final cash offer from asset management firm DBAYMarch 10, 2025 | reuters.comAlliance Pharma And 2 Other UK Penny Stocks With Promising FundamentalsFebruary 27, 2025 | finance.yahoo.comAlliance Pharma Expected Revenue Falls on Consumer Healthcare DeclineJanuary 31, 2025 | marketwatch.comAlliance Pharma Regulatory NewsJanuary 31, 2025 | lse.co.ukSee More Headlines APH Stock Analysis - Frequently Asked Questions How were Alliance Pharma's earnings last quarter? Alliance Pharma plc (LON:APH) posted its quarterly earnings results on Tuesday, April, 8th. The company reported $4.32 earnings per share for the quarter. Alliance Pharma had a negative trailing twelve-month return on equity of 15.24% and a negative net margin of 18.34%. How do I buy shares of Alliance Pharma? Shares of APH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Alliance Pharma own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alliance Pharma investors own include boohoo group (BOO), BP (BP), Vodafone Group Public (VOD), Aviva (AV), Babcock International Group (BAB), BAE Systems (BA) and The Gym Group (GYM). Company Calendar Last Earnings4/08/2025Today8/02/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryElectronic Equipment Current SymbolLON:APH CIKN/A Webwww.alliancepharma.co.uk Phone+44-1249-466966FaxN/AEmployees91,000Year FoundedN/APrice Target and Rating Average Price Target for Alliance PharmaGBX 6,250 High Price TargetGBX 6,250 Low Price TargetGBX 6,250 Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)GBX (6.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.04Net Income-£33.65 million Net Margins-18.34% Pretax MarginN/A Return on Equity-15.24% Return on Assets5.98% Debt Debt-to-Equity Ratio46.27 Current Ratio2.93 Quick Ratio1.42 Sales & Book Value Annual Sales£183.50 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow7.87 Book ValueGBX 41.25 per share Price / BookN/AMiscellaneous Outstanding Shares541,444,969Free FloatN/AMarket Cap£350.32 million OptionableNot Optionable Beta0.67 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (LON:APH) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alliance Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Alliance Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.